This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, A. H. Articles by El-Rifai, W. Search for Related Content PubMed PubMed Citation Articles by Johnson, A. H. Articles by El-Rifai, W.

(American Journal of Pathology. 2005;167:577-584.)
© 2005 American Society for Investigative Pathology

Expression of Tight-Junction Protein Claudin-7 Is an Early Event in Gastric Tumorigenesis

Adam H. Johnson^*, Henry F. Frierson, Alexander Zaika^*, Steven M. Powell^*, James Roche^*, Sheila Crowe^*, Christopher A. Moskaluk and Wa’el El-Rifai^*

From the Digestive Health Center of Excellence^* and the Department of Pathology, University of Virginia Health System, Charlottesville, Virginia

Trefoil factor-1 (Tff1) expression is remarkably down-regulated in nearly all human gastric cancers. Therefore, we used the Tff1 knockout mouse model to detect molecular changes in preneoplastic gastric dysplasia. Oligonucleotide microarray gene expression analysis of gastric dysplasia of Tff1 –/– mice was compared to that of normal gastric mucosa of wild-type mice. The genes most overexpressed in Tff1–/– mice included claudin-7 (CLDN7), early growth response-1 (EGR1), and epithelial membrane protein-1 (EMP1). Quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry showed that Cldn7 was overexpressed in all 10 Tff1–/– gastric dysplasia samples. Comparison with our serial analysis of gene expression database of human gastric cancer revealed similar deregulation in human gastric cancers. Quantitative real-time reverse transcriptase-polymerase chain reaction of human gastric adenocarcinoma samples indicated that, of these three genes, CLDN7 was the most frequently up-regulated gene. Using immunohistochemistry, both mouse and human gastric glands overexpressed Cldn7 in dysplastic but not surrounding normal glands. Cldn7 expression was observed in 30% of metaplasia, 80% of dysplasia, and 70% of gastric adenocarcinomas. Interestingly, 82% of human intestinal-type gastric adenocarcinomas expressed Cldn7 whereas diffuse-type gastric adenocarcinomas did not (P < 0.001). These results suggest that Cldn7 expression is an early event in gastric tumorigenesis that is maintained throughout tumor progression.

This article has been cited by other articles:

				C. Darido, M. Buchert, J. Pannequin, P. Bastide, H. Zalzali, T. Mantamadiotis, J.-F. Bourgaux, V. Garambois, P. Jay, P. Blache, et al. Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells Cancer Res., June 1, 2008; 68(11): 4258 - 4268. [Abstract] [Full Text] [PDF]

				S. Kuhn, M. Koch, T. Nubel, M. Ladwein, D. Antolovic, P. Klingbeil, D. Hildebrand, G. Moldenhauer, L. Langbein, W. W. Franke, et al. A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression Mol. Cancer Res., June 1, 2007; 5(6): 553 - 567. [Abstract] [Full Text] [PDF]

				S. Boireau, M. Buchert, M. S. Samuel, J. Pannequin, J. L. Ryan, A. Choquet, H. Chapuis, X. Rebillard, C. Avances, M. Ernst, et al. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma Carcinogenesis, February 1, 2007; 28(2): 246 - 258. [Abstract] [Full Text] [PDF]

				P. A. McChesney, S. E. Aiyar, O.-J. Lee, A. Zaika, C. Moskaluk, R. Li, and W. El-Rifai Cofactor of BRCA1: A Novel Transcription Factor Regulator in Upper Gastrointestinal Adenocarcinomas Cancer Res., February 1, 2006; 66(3): 1346 - 1353. [Abstract] [Full Text] [PDF]